The Medicines Company to Host Infectious Disease Care Investor and Analyst
Meeting on September 24, 2014
PARSIPPANY, N.J. -- August 4, 2014
The Medicines Company (NASDAQ:MDCO) has scheduled an Infectious Disease Care
Investor and Analyst meeting for Wednesday, September 24, 2014 from 8:30 am to
12:00 noon. The event will be held at the Company’s Global Center 1 at 8
Sylvan Way in Parsippany, NJ. The meeting is being hosted to highlight The
Medicines Company’s emerging core business in Infectious Disease Care.
Investors and Analysts interested in registration information can request an
invitation by emailing firstname.lastname@example.org.
About The Medicines Company
The Medicines Company's purpose is to save lives, alleviate suffering and
contribute to the economics of healthcare by focusing on 3,000 leading
acute/intensive care hospitals worldwide. Its vision is to be a leading
provider of solutions in three areas: acute cardiovascular care, surgery and
perioperative care, and serious infectious disease care. The company operates
in the Americas, Europe and the Middle East, and Asia Pacific regions with
global centers today in Parsippany, NJ, USA and Zurich, Switzerland.
The Medicines Company
Neera Dahiya Ravindran, MD, +1-973-290-6044
Vice President, Investor Relations & Strategic Planning
Press spacebar to pause and continue. Press esc to stop.